약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 1.

Table. 1.

Discrepancy in the Continuous Glucose Monitoring (CGM) devices approved by Ministry of Food and Drug Safety and reimbursed by National Health Insurance Service

Manufacturer Model (Product) Name Ministry of Food and Drug Safety National Health Insurance Service
Resource: https://udiportal.mfds.go.kr/search/data/P02_01 Resource: https://www.nhis.or.kr/nhis/policy/retrieveDiabmlPatCsmpMtatxRegPrdctMgmt.do
Abbott Diabetes Care Limited FreeStyle Libre Approved (2018.11.14) Not listed
Dexcom, Inc. Dexcom G6ⓡ Continuous Glucose Monitoring System Approved (2020.02.25) Listed (reimbursable)
Dexcom G5ⓡ Mobile Continuous Glucose Monitoring System Approved (2018.07.31)
Withdrawn (2022.07.19)
Listed (reimbursable)
Medtronic Inc. MMT-7820ME or MMT-7820 Approved (2018.02.27) Listed (reimbursable)
MMT-7820LME or MMT-7820L Approved (2018.02.27) Listed (reimbursable)
MMT-7731 Approval information not available Listed (reimbursable)
MMT-7775 Approval information not available Listed (reimbursable)
MMT-7810 Approval information not available Listed (reimbursable)
MMT-7811W3 Approval information not available Listed (reimbursable)
MMT-7821ME Approval information not available Listed (reimbursable)
MMT-7821LME Approval information not available Listed (reimbursable)
MMT-7910W5 Approval information not available Listed (reimbursable)
MMT-7911W5 Approval information not available Listed (reimbursable)
Yakhak Hoeji 2022;66:161-8 https://doi.org/10.17480/psk.2022.66.4.161
© 2022 Yakhak Hoeji